Bromadol BDPC, a relatively man-made opioid, exhibits unique pharmacological qualities. This compound mostly works as the incomplete mu-opioid binding site stimulant, but demonstrates significant influence with the kappa binding site and also. The mixed effect leads to in a complex set regarding consequences, such as pain reduction, drowsiness,